ClinicalTrials.Veeva

Menu

Better Lithotripsy and Ureteroscopy Evaluation of Stenting (BLUES)

University of Michigan logo

University of Michigan

Status

Completed

Conditions

Renal Stone
Ureteral Stone

Treatments

Device: Silicone (Coloplast Imajin Hydro) ureteral stent
Device: Non-silicone (Polyurethane/Percuflex) ureteral stent (any manufacturer)

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT05026710
HUM00199486

Details and patient eligibility

About

This multi-center trial is being completed to compare patient outcomes related to the Imajin silicone stent in comparison to non-silicone polyurethane stents after ureteroscopy.

Eligible participants will be enrolled and randomly assigned to receive the Imajin silicone stent or a non-silicone stent. In addition, the participants will complete questionnaires and have follow-up information collected (approximately 60 days after surgery).

The trial hypothesizes that a ureteral stent made of silicone, will have superior outcomes when compared to non-silicone stents.

Enrollment

224 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Stated willingness to comply with all study procedures and availability for the duration of the study

  • Diagnosed with unilateral renal and/or ureteral stones with the largest less than or equal to (≤)2.0 cm in size measured on abdominal x-ray, Ultrasound or computerized tomography (CT) scan

    • Renal stone defined as only renal location of stone(s).
    • Ureteral stone defined as ureteral only or ureteral and renal stone(s).
  • Planned unilateral ureteroscopy with stent placement without stent string.

  • Ability to take oral medication.

  • Ability and willingness to complete and adhere to survey questions and responses throughout study duration.

Exclusion criteria

  • Known planned secondary or staged procedure
  • Presence of anatomical anomalies (for example (e.g.) solitary, horseshoe, fused crossed ectopia, pelvic kidney)
  • Presence of any prior urinary diversion (e.g. ileal conduit, orthotopic neobladder)
  • Presence of any indwelling ureteral stent prior to ureteroscopy
  • Presence of any indwelling nephrostomy tube prior to ureteroscopy
  • Ancillary ureteroscopy to treat residual fragments after percutaneous renal stone surgery
  • Renal stone located in calyceal diverticulum
  • No indication for stent placement (e.g. spontaneous passage)
  • Bladder stone location.
  • Pregnancy or lactation
  • Known allergic reactions to polyurethane or silicone

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

224 participants in 2 patient groups

Silicone (Coloplast Imajin Hydro) ureteral stent
Experimental group
Treatment:
Device: Silicone (Coloplast Imajin Hydro) ureteral stent
Non-silicone (Polyurethane/Percuflex) ureteral stent (any manufacturer).
Experimental group
Treatment:
Device: Non-silicone (Polyurethane/Percuflex) ureteral stent (any manufacturer)

Trial documents
1

Trial contacts and locations

10

Loading...

Central trial contact

Elaina Shoemaker; Kyran Groce

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems